SCHEMBL21046113

SCHEMBL21046113

c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3-c2ccc(-c3cccc(-c4ccccc4)c3-c3ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
ADORA3 P0DMS8 2/20 0.35
ADORA2A P29274 2/20 0.35
ADORA2B P29275 2/20 0.35
ADORA1 P30542 2/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
RXRA P19793 1/20 0.34
KDM4E B2RXH2 2/20 0.34
LMNA P02545 2/20 0.34
GLA P06280 1/20 0.34
PDE10A Q9Y233 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
AVPR1A P37288 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26931253 0.90 NR3C1 (0.37) NR3C1KMT2AMEN1ALDH1A1MAPT
SCHEMBL22126298 0.90 NR3C1 (0.37) NR3C1KMT2AMEN1ALDH1A1MAPT
SCHEMBL16441599 0.89 KDM4E (0.39) NR3C1KMT2AMEN1ALDH1A1MAPT
SCHEMBL15248555 0.89 NR3C1 (0.42) NR3C1KMT2AMEN1ALDH1A1MAPT
SCHEMBL22763388 0.89 NR3C1 (0.42) NR3C1KMT2AMEN1ALDH1A1MAPT
SCHEMBL21763739 0.89 NR3C1 (0.42) NR3C1KMT2AMEN1ALDH1A1MAPT
SCHEMBL22544982 0.89 NR3C1 (0.42) NR3C1KMT2AMEN1ALDH1A1MAPT
SCHEMBL17950355 0.89 NR3C1 (0.42) NR3C1KMT2AMEN1ALDH1A1MAPT
SCHEMBL21365764 0.89 NR3C1 (0.42) NR3C1KMT2AMEN1ALDH1A1MAPT
SCHEMBL22763780 0.89 NR3C1 (0.42) NR3C1KMT2AMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190173017-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190173017-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, ALDH1A2, CYBA NR3C1 2604/4885KMT2A 4204/4885MEN1 2756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.